Prognostic Significance of Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography in Anal Squamous Cell Carcinoma A Systematic Review and a Meta-Analysis

سال انتشار: 1397
نوع سند: مقاله کنفرانسی
زبان: انگلیسی
مشاهده: 523

نسخه کامل این مقاله ارائه نشده است و در دسترس نمی باشد

این مقاله در بخشهای موضوعی زیر دسته بندی شده است:

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

RINMMICMED22_004

تاریخ نمایه سازی: 30 آذر 1398

چکیده مقاله:

Purpose: Prognostic significance of Fluorine-18 Fluorodeoxyglucose positron emission tomography (18F-FDG-PET) in anal squamous cell carcinoma (SCC) has been evaluated in several studies; however, the results seem to be controversial and no consensus exists about its predictive capability. The current meta-analysis was carried out to comprehensively investigate the prognostic significance of 18F-FDG-PET parameters in patients with anal SCC.Methods: A comprehensive literature search of PubMed/MEDLINE and Scopus databases was performed to retrieve pertinent articles published until August 5th 2018, concerning the prognostic significance of 18F-FDG-PET in patients with anal SCC. No language restriction was used. Several prognostic factors were reported for progression-free survival (PFS) and overall survival (OS) including pretreatment maximum standardized uptake value (SUVmax), metabolic tumor volume (MTV), inguinal nodal uptake, and metabolic response to therapy.Results: Eleven studies (741 patients) were included. The pooled hazard ratio (HR) for the probability of PFS were 5.36 [95% confidence interval (95%CI): 3.12-9.21, p<0.001] for metabolic response to therapy and 1.98 [95%CI: 1.26-3.12, p=0.003] for SUVmax. The pooled HR for the probability of OS was 5.87 [3.02-11.39, p<0.0001] for metabolic response to therapy. On the other hand, the study revealed that the pooled HRs of MTV and inguinal nodal uptake for PFS were 1.56 [95%CI: 0.96-2.53, p=0.072] and 1.79 [95%CI: 1-3.21, p=0.051], respectivelyConclusions: Our findings propose that 18F-FDG-PET parameters could serve as prognostic indicators in anal SCC

نویسندگان

Ramin Sadeghi

Nuclear Medicine Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

Sara Harsini

Association of Nuclear Medicine and Molecular Imaging, Universal Scientific Education and Research Network, Tehran, Iran - Students’ Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran - Research Center for Nuclear Medicine, Sh

Mohammad Ali Qodsi Rad

Nuclear Medicine Department, Shohadaye Tajrish Hospital, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Vahid Reza Dabbagh

Nuclear Medicine Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

Giorgio Treglia

Clinic of Nuclear Medicine and PET/CT Center, Ente Ospedaliero Cantonale, Oncology Institute of S۷. Health Technology Assessment Unit, Ente Ospedaliero Cantonale, Bellinzona, Switzerland - Giorgio Treglia, MD MSc (HTA), Clinic of Nuclear Medicine and PET/